Companies AcuityMD

AcuityMD

Boston

250 Total Employees

Year Founded: 2019

View Website

We're Hiring!

Engineering 2 Sales 2 Consulting 1 AI & Machine Learning 1 Marketing 1 Program & Project Management 1

View all jobs

AcuityMD Company Growth, Stability & Outlook in Boston

Updated on September 09, 2026

What's the stability & growth outlook for AcuityMD?

The Boston office is characterized by a high-growth environment supported by substantial capital, strong market traction, and visible revenue expansion. Together, these dynamics suggest the Boston location offers resources and momentum conducive to executing ambitious product and customer initiatives.

Key Insight for Candidates

Venture-backed hypergrowth with sustained customer expansion and frequent product launches defines AcuityMD’s Boston office. For candidates in Boston, this means strong resourcing and momentum to build AI/data capabilities and integrations, high‑visibility work with major MedTech enterprises, and a stable, scaling environment validated by external recognition and late‑stage funding.

Evidence in Action

Continuous Product Shipments — AcuityMD Contracts (Sept 24, 2024), Care Journeys (Oct 15, 2024), and “AcuityAI” (April 2026) showcase continued platform build‑out. Boston employees see a clear roadmap and new internal mobility as products expand across data, AI, and commercial workflows.
Funding-Backed Platform Investment — Series B $45M (June 4, 2024) and Series C $80M (April 21, 2026), valuing AcuityMD at about $955M, fund expansion of AI and data products. Boston employees gain confidence in runway and resources for roadmap execution, supporting career development and sustained platform improvements.

Positive Themes About AcuityMD

Investor Backing & Capital Strength: In Boston, teams operate within a company that recently secured significant late-stage funding at a near-unicorn valuation. This capital provides resources to expand AI capabilities and data products.
Strong Market Position & Advantage: Work in the Boston office supports a platform adopted by hundreds of MedTech companies, including many of the industry's largest. This breadth of enterprise penetration signals a durable competitive footing.
Strong Revenue Growth: Recognition on the 2026 Inc. 5000 for exceptional multi-year revenue growth reflects a rapidly scaling business context. This momentum frames local execution within a company expanding quickly across customers and revenue.